Nymox Pharmaceutical Reports 2005 Financial Results

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--March 15, 2006--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the year ended December 31, 2005. Product sales increased by 32% and amounted to $424,506 for 2005, compared to $321,895 for 2004. Nymox currently has $11.9 million in financing available from its most recent October 21, 2005 financing. Nymox reported a net loss of $3,584,528, or $0.14 per share, compared to $3,745,625, or $0.15 per share for 2004. The weighted, diluted average number of common shares at December 31, 2005 was 26,103,704, compared to 25,103,252 at December 31, 2004.

Back to news